FDA asks VaxGen to delay further trials of anthrax vaccine (New Ratings)
Published by Yahoo! News Search Results for Food and Drug Admin November 4th, 2006 in Yahoo FDA News, Regulatory AffairsNEW YORK, November 4 (newratings.com) – The US Food & Drug Administration (FDA) has asked VaxGen Inc ( VXGN.NAS ) to postpone the advanced testing of its anthrax vaccine owing to fears that the drug may not be stable enough to pass the trials. VaxGen’s share price fell by 56% to $1.77 on Friday.